Cargando…
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy
Targeting B7-H3 over-expressed tumor cells with anti-B7-H3 monoclonal antibodies inhibits tumor growth. Here we demonstrated the expression of B7 family homologue 3 (B7-H3) in a wide range of human tumor cells and further investigated whether B7-H3 could be served as a target for T-cell mediated imm...
Autores principales: | Ma, Juan, Ma, Pan, Zhao, Chenghai, Xue, Xin, Han, Huamin, Liu, Changzhen, Tao, Hua, Xiu, Weigang, Cai, Jia, Zhang, Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045411/ https://www.ncbi.nlm.nih.gov/pubmed/27121051 http://dx.doi.org/10.18632/oncotarget.8784 |
Ejemplares similares
-
HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy
por: Ma, Juan, et al.
Publicado: (2013) -
Correction: HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy
por: Ma, Juan, et al.
Publicado: (2013) -
The immunostimulatory effects of retinoblastoma cell supernatant on dendritic cells
por: Ma, Juan, et al.
Publicado: (2014) -
Targeting immunotherapy for bladder cancer using anti‐CD3× B7‐H3 bispecific antibody
por: Ma, Wanru, et al.
Publicado: (2018) -
AG490 reverses phenotypic alteration of dendritic cells by bladder cancer cells
por: Xiu, Weigang, et al.
Publicado: (2018)